CPS Technologies Corp. — Q1 2024 Form 10-Q
Business and period: CPS manufactures custom metal-matrix composite products, electronic housings and packages, and lightweight armor for electronics, power generation, transportation, automotive, and defense markets. This unaudited report covers the fiscal quarter ended March 30, 2024; comparisons are with the quarter ended April 1, 2023 unless noted.
Financial results and liquidity
| Metric | Q1 2024 | Prior-year quarter / comparison |
|---|---|---|
| Revenue | $5.913 million | $7.100 million; down 17% |
| Gross margin | $0.906 million; 15% of revenue | $2.245 million; 32% of revenue |
| SG&A expense | $1.166 million | $1.551 million |
| Operating income (loss) | $(0.260) million | $0.694 million |
| Net income (loss) | $(0.143) million; $(0.01) per share | $0.459 million; $0.03 per share |
| Cash from operations | $0.129 million | $(0.719) million |
| Capital expenditures | $0.263 million | $0.177 million |
| Cash and cash equivalents | $8.668 million at March 30, 2024 | $8.814 million at December 30, 2023 |
Current assets were $17.547 million and current liabilities were $3.664 million at quarter-end. Net accounts receivable was $3.876 million, down from $4.472 million at year-end; DSO improved to 59 days from 60. Inventory was $4.611 million, versus $4.582 million. Total liabilities were $3.833 million, including a $43,478 note payable and $297,000 in operating lease liabilities.
The company had no borrowings on its $3.0 million secured revolving credit line; its borrowing base permitted the full $3.0 million to be drawn. Cash declined by $146,000 during the quarter. Share-based compensation expense was $161,000.
Material changes and management commentary
- Revenue fell 17%, which management attributed mainly to a major customer reducing purchases while working down excess inventory, and machine time being used for continued testing related to quality issues.
- Lower volume and quality testing reduced gross margin to 15% from 32%, with fixed manufacturing costs spread over fewer sales. Lower SG&A, partly from reduced variable compensation and commissions, only partly offset the gross-margin decline.
- Management said it is cautiously optimistic that identified quality issues have been resolved, but testing continued during the quarter and used capacity otherwise available for customer production.
- Management expects to fund operations through the remainder of 2024 using operating cash and existing cash balances, and believes cash is sufficient for the foreseeable future. The filing cautions that this depends on revenue, spending, and operational goals.
Risks, contingencies, and other items
- Customer concentration is a key risk: CPS sells to a limited number of customers, and losing one could require additional external financing. Failure to generate sufficient revenue, raise capital, or reduce discretionary spending could adversely affect business objectives.
- Inflation has raised raw-material, operating, and labor costs. CPS has generally passed costs through to customers, but says future pass-through is not assured and pricing agreements can delay adjustments.
- The company reported no direct impact from conflicts in Ukraine or Israel and Gaza, but identified possible indirect supply-chain and energy-cost impacts.
- A former European sales representative’s attorney claims termination compensation is due under European law. CPS disputes the claim and estimates any loss to be immaterial; litigation may follow.
- The Norton facility lease expires in February 2026. Renewal options through February 2032 were not included in lease liabilities because the company was not reasonably certain it would exercise them.
- Management reported disclosure controls and procedures were effective and no material change in internal control over financial reporting during the quarter. No material changes to the 2023 Form 10-K risk factors were reported.
Important facts for investors to verify
- Whether the large customer’s inventory reduction and resulting lower orders persist, and how much CPS depends on that customer.
- Whether quality issues are fully resolved, how long related testing will constrain production, and whether customer demand and gross margins recover.
- Whether operating cash generation and the $8.7 million cash balance remain adequate if revenue stays weak; also verify availability and terms of the secured credit line.
- Whether cost inflation can continue to be passed on, particularly under customer pricing agreements, and its effect on margins.
- Any developments in the former representative’s compensation claim and any resulting financial exposure.